نتائج البحث - Jed G. Nuchtern

تنقيح النتائج
  1. 1
    Targeting of GD2-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes

    Targeting of GD2-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes حسب Claudia Rössig, Catherine M. Bollard, Jed G. Nuchtern, Durriya A. Merchant, Malcolm K. Brenner

    منشور في 2001
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Permanent hemodialysis vascular access survival in children and adolescents with end-stage renal disease

    Permanent hemodialysis vascular access survival in children and adolescents with end-stage renal disease حسب Rita D. Sheth, Mary L. Brandt, Eileen D. Brewer, Jed G. Nuchtern, Arundhati S. Kale, Stuart L. Goldstein

    منشور في 2002
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Plasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates

    Plasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates حسب Jodi A. Muscal, Yongkai Sun, Jed G. Nuchtern, Robert C. Dauser, Leticia H. McGuffey, Brian Gibson, Stacey L. Berg

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    A distinct “side population” of cells with high drug efflux capacity in human tumor cells

    A distinct “side population” of cells with high drug efflux capacity in human tumor cells حسب Charlotte Hirschmann-Jax, Angela E. Foster, Gerald Wulf, Jed G. Nuchtern, Thomas Jax, U. Göbel, Margaret A. Goodell, Malcolm K. Brenner

    منشور في 2004
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Radiation Therapy to the Primary and Postinduction Chemotherapy MIBG-Avid Sites in High-Risk Neuroblastoma

    Radiation Therapy to the Primary and Postinduction Chemotherapy MIBG-Avid Sites in High-Risk Neuroblastoma حسب Ali Mazloom, Chrystal U. Louis, Jed G. Nuchtern, Eugene S. Kim, Heidi V. Russell, Wendy Allen‐Rhoades, Robert A. Krance, Arnold C. Paulino

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop Is Required for Interleukin (IL)-1-mediated Optimal NFκB and AP-1 Activation as Well as IL-6 Gene Expression

    Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop Is Required for Interleukin (IL)-1-mediated Optimal NFκB and AP-1 Activation as Well as IL-6 Gene Expression حسب Yang Yu, Ningling Ge, Min Xie, Wenjing Sun, Susan M. Burlingame, Amy Kun Pass, Jed G. Nuchtern, Dekai Zhang, Songbin Fu, Michael Schneider, Jia Fan, Jianhua Yang

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    <i>Aurora A</i> is a negative prognostic factor and a new therapeutic target in human neuroblastoma

    <i>Aurora A</i> is a negative prognostic factor and a new therapeutic target in human neuroblastoma حسب Xiaoying Shang, Susan M. Burlingame, M. Fatih Okcu, Ningling Ge, Heidi V. Russell, Rachel A. Egler, Rodney D. David, Sanjeev A. Vasudevan, Jianhua Yang, Jed G. Nuchtern

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy

    TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy حسب Yihui Fan, Jin Cheng, Sanjeev A. Vasudevan, Roma H. Patel, Liang Li, Xin Xu, Yanling Zhao, Wei Jia, Fengmin Lu, Hong Zhang, Jed G. Nuchtern, Eugene S. Kim, Jianhua Yang

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants

    A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants حسب Jed G. Nuchtern, Wendy B. London, Carol E. Barnewolt, Arlene Naranjo, Patrick McGrady, James D. Geiger, Lisa Diller, Mary Lou Schmidt, John M. Maris, Susan L. Cohn, Robert C. Shamberger

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Characteristics and outcomes in children with undifferentiated embryonal sarcoma of the liver: A report from the National Cancer Database

    Characteristics and outcomes in children with undifferentiated embryonal sarcoma of the liver: A report from the National Cancer Database حسب Yan Shi, Yesenia Rojas, Wei Zhang, Elizabeth A. Beierle, John J. Doski, Melanie Goldfarb, Adam B. Goldin, Kenneth W. Gow, Monica Langer, Rebecka L. Meyers, Jed G. Nuchtern, Sanjeev A. Vasudevan

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis

    USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis حسب Yihui Fan, Zhenghu Chen, Sanjeev A. Vasudevan, Jinzhuang Dou, H Zhang, Roma H. Patel, Iván Hurtado T., Yesenia Rojas, Yanling Zhao, Yan Yu, H Zhang, Jason M. Shohet, Jed G. Nuchtern, Eugene S. Kim, Jianhua Yang

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Effects of socioeconomic status on children with well-differentiated thyroid cancer

    Effects of socioeconomic status on children with well-differentiated thyroid cancer حسب Evan F. Garner, Ilan I. Maizlin, Matthew B. Dellinger, Kenneth W. Gow, Melanie Goldfarb, Adam B. Goldin, John J. Doski, Monica Langer, Jed G. Nuchtern, Sanjeev A. Vasudevan, Mehul V. Raval, Elizabeth A. Beierle

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways

    A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways حسب Zhenghu Chen, Yihui Fan, Xin Xu, H Zhang, Jun Dou, Ying Tang, Xiangyu Zhong, Yesenia Rojas, Yang Yu, Yanling Zhao, Sanjeev A. Vasudevan, H Zhang, Jed G. Nuchtern, Eugene S. Kim, Xiong Chen, Fei Lu, J Yang

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

    The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report حسب Tom Monclair, Garrett M. Brodeur, Peter F. Ambros, Hervé J. Brisse, Giovanni Cecchetto, Keith Holmes, Michio Kaneko, Wendy B. London, Katherine K. Matthay, Jed G. Nuchtern, Dietrich von Schweinitz, Thorsten Simon, Susan L. Cohn, Andrew D.J. Pearson

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling

    mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling حسب Huiyuan Zhang, Jun Dou, Yang Yu, Yanling Zhao, Yihui Fan, Jin Cheng, Xin Xu, Wei Liu, Shan Guan, Zhenghu Chen, Yan Shi, Roma H. Patel, Sanjeev A. Vasudevan, Peter E. Zage, Hong Zhang, Jed G. Nuchtern, Eugene S. Kim, Songbin Fu, Jianhua Yang

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma

    Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma حسب Xiaoying Shang, Sanjeev A. Vasudevan, Yang Yu, Ning Ge, Andrew D. Ludwig, Catherine L. Wesson, K. Wang, S. M. Burlingame, Y-j Zhao, Pulivarthi H. Rao, Xuan Lu, Heidi V. Russell, M. Fatih Okcu, John Hicks, Jason M. Shohet, Lawrence A. Donehower, Jed G. Nuchtern, J Yang

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group

    Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group حسب Meredith S. Irwin, Arlene Naranjo, Fan F. Zhang, Susan L. Cohn, Wendy B. London, Julie M. Gastier‐Foster, Nilsa C. Ramirez, Ruthann Pfau, Shalini C. Reshmi, Elizabeth M. Wagner, Jed G. Nuchtern, Shahab Asgharzadeh, Hiroyuki Shimada, John M. Maris, Rochelle Bagatell, Julie R. Park, Michael D. Hogarty

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study

    Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study حسب Rochelle Bagatell, Kieran McHugh, Arlene Naranjo, Collin Van Ryn, Chaim Kirby, Penelope Brock, Karen Lyons, Lisa J. States, Yesenia Rojas, Alexandra Miller, Sam Volchenboum, Thorsten Simon, Barbara Krug, Sabine Sarnacki, Dominique Valteau‐Couanet, Dietrich von Schweinitz, Birgit Kammer, Claudio Granata, Luca Pio, Julie R. Park, Jed G. Nuchtern

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting

    Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting حسب Julie R. Park, Rochelle Bagatell, Susan L. Cohn, Andrew D.J. Pearson, Judith G. Villablanca, Frank Berthold, Susan A. Burchill, Ariane Boubaker, Kieran McHugh, Jed G. Nuchtern, Wendy B. London, Nita L. Seibel, O. Wolf Lindwasser, John M. Maris, Penelope Brock, Gudrun Schleiermacher, Ruth Ladenstein, Katherine K. Matthay, Dominique Valteau‐Couanet

    منشور في 2017
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney

    Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney حسب Angshumoy Roy, Vijetha Kumar, Barry Zorman, Erica Fang, Katherine Haines, HarshaVardhan Doddapaneni, Oliver Hampton, Simon White, Abhishek Bavle, Nimesh R. Patel, Karen W. Eldin, John Hicks, Dinesh Rakheja, Patrick J. Leavey, Stephen X. Skapek, James F. Amatruda, Jed G. Nuchtern, Murali Chintagumpala, David A. Wheeler, Sharon E. Plon, Pavel Sumazin, D. Williams Parsons

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: